Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3134971

CC(N)CCc1cc(F)c(F)cc1F.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 13/20 0.42
DPP7 Q9UHL4 6/20 0.38
DPP9 Q86TI2 5/20 0.38
DPP8 Q6V1X1 3/20 0.36
FAP Q12884 2/20 0.36
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
SLC1A3 P43003 1/20 0.35
SLC1A2 P43004 1/20 0.35
SLC1A1 P43005 1/20 0.35
CYP3A4 P08684 1/20 0.34
KCNH2 Q12809 1/20 0.34
GABRP O00591 2/20 0.34
GABRD O14764 2/20 0.34
GABRA1 P14867 2/20 0.34
GABRB1 P18505 2/20 0.34
GABRG2 P18507 2/20 0.34
GABRB3 P28472 2/20 0.34
GABRA5 P31644 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4697922 0.85 DPP4 (0.55) DPP4DPP7DPP9DPP8FAP
Adipic Acid SCHEMBL13729711 0.84 GABRP (0.44) DPP4DPP7DPP9DPP8FAP
Hydrochloric Acid SCHEMBL13730064 0.84 DPP4 (0.53) DPP4DPP7DPP9DPP8FAP
Phosphoric Acid SCHEMBL13730179 0.83 DPP4 (0.46) DPP4DPP7DPP9DPP8FAP
Phosphoric Acid SCHEMBL14128619 0.81 DPP4 (0.45) DPP4DPP7DPP9DPP8FAP
SCHEMBL15155703 0.77 GABRR1 (0.45) DPP4HDAC1HDAC8
Gentisic Acid SCHEMBL13729892 0.76 CA1 (0.49) CYP3A4
Trifluoroacetic Acid SCHEMBL13729613 0.76 DPP4 (0.49) DPP4DPP7DPP9DPP8FAP
SCHEMBL25186554 0.76 USP2 (0.43) DPP4DPP7DPP9DPP8FAP
SCHEMBL3717133 0.76 USP2 (0.43) DPP4DPP7DPP9DPP8FAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2681220-A2 NOVEL SALTS OF DPP-IV INHIBITOR Cadila Healthcare Limited (IN) 2014-01-08 EP claimed
WO-2012147092-A2 NOVEL SALTS OF DPP-IV INHIBITOR CADILA HEALTHCARE LIMITED (IN) 2012-11-01 WO claimed
EP-2205083-A1 SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS Merck Sharp & Dohme Corp. (US) 2010-07-14 EP claimed
WO-2009045382-A1 SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS MERCK & CO., INC. (US) 2009-04-09 WO claimed
EP-2681220-A2 NOVEL SALTS OF DPP-IV INHIBITOR Cadila Healthcare Limited (IN) 2014-01-08 EP disclosed
WO-2012147092-A2 NOVEL SALTS OF DPP-IV INHIBITOR CADILA HEALTHCARE LIMITED (IN) 2012-11-01 WO disclosed